For breast cancer specifically, the intravenous administration of platelets conjugated to PD-L1 blocking antibodies post-surgery in a murine model of this disease led to decreased recurrence and metastasis levels, and improved survival (61). This evidence concerns the gene CD274 and breast carcinoma.